The Pharmacy Pre-approval Program includes four types of reviews:
You can use our Rx Search tool to see if a drug falls into one or more of these categories.
To request a review, the pharmacy or the provider must contact our Pharmacy services center at 888-261-1756 or fax in a drug-specific online form (see Pre-approval Drugs section).
Sometimes a pharmacy can do a one-time override for urgently needed medication.
Learn more about emergency overrides.
A formulary exception review is required if the Rx plan listed on the member's ID card is M1, M2, M4 or B2, and the drug you've selected in the Rx Search tool displays the non-formulary symbol. For these drugs, submit a review using the Pharmacy Formulary Exception Request fax form. If we approve the exception, your cost will be charged, based on whether the drug is generic, brand, or specialty. Learn more about drug benefit levels.
Once the medication is reviewed, we fax a decision to the requesting provider and send the member a confirmation letter about the prescription coverage decision.
Pharmacy reviewers at Premera apply company medical policy to assist in the determination of medical necessity. Our medical policies are available to contracted physicians and providers upon request. Specific criteria related to a medical decision for
a patient can be requested by calling Pharmacy Services at 888-261-1756, option 2. View our medical
Our formulary, including prior authorization criteria, restrictions and preferences, and plan limits on dispensing quantities or duration of therapy are available via Rx search.
Providers can contact pharmacy management staff at 888-261-1756, option 1, to discuss specific prior authorization, step therapy, quantity limits,
exception request criteria for unusual cases, and other utilization management
requirements/procedures for drugs covered under the pharmacy benefit. Review
requests for medical necessity can also be faxed to 888-260-9836. Formulary
updates are communicated on a quarterly basis in provider news.
Premera updates the formulary and pharmacy prior authorization criteria routinely throughout the year. The Pharmacy and Therapeutics Committee approves all formularies in May. To see the most current information, visit our pharmacy
Premera has added new review criteria based on clinical best practices and approval by an independent pharmacy and therapeutics committee. The program is designed to promote appropriate drug selection, length of therapy, and utilization of specific drugs
while improving the overall quality of care.
Drugs may be added or deleted from this list without prior notification. If you have questions concerning the Pharmacy Prior Authorization Edit Program, please call the Pharmacy Services Center at 888-261-1756 or fax 888-260-9836, Monday through Friday,
8 a.m. to 5 p.m.
Note: This information does not apply to our Premera Blue Cross Medicare Advantage plans. For more information on the Premera Blue Cross Medicare Advantage formulary, Prior Authorization Criteria, or Pharmacy Network, see our prescription drug documents and forms.
Medications for certain conditions-such as migraines, diabetes, or high blood pressure-may need to meet certain requirements before a prescription is covered. See the Pre-approval Drugs section to see if the drug requires a pre-approval, quantity limit, or step therapy review.
Type in the name of the drug to view pre-approval criteria, the drug's corresponding medical policy, and a link to an online fax form. As another option, you can use the Pharmacy Pre-approval Request fax form to submit all types of pharmacy authorization requests.
Note: The Rx search tool shows drugs that require pharmacy pre-approval common to all plans. For drug review requirements specific to a customer's plan, log in to My Rx Choices via MyPharmacyPlus™ to view drug review requirements specific to their plan.
By replacing faxing and phone calls, ePA gives you more time for patient care.
To submit a pharmacy PA, use your electronic health record or visit
ExpressPAth®. Approvals are often returned within minutes.